Nanoparticle-Based Drug Delivery in Cancer Treatment

Nanoparticle-Based Drug Delivery in Cancer Treatment

Madkour, Loutfy H.

Taylor & Francis Ltd

03/2022

534

Dura

Inglês

9781032135205

15 a 20 dias

1696

Descrição não disponível.
Chapter 01

The advantages and versatility of carrier-free nanodrugs and nanoparticles systems for cancer therapy

Chapter 02

Strategies, design, and chemistry in siRNA delivery vehicles systems for cancer therapy

Chapter 03

DNA/RNA nanoparticles structures for siRNA deliver applications

Chapter 04

Co-delivery in nanoparticle-based siRNA for cancer therapy

Chapter 05

Small interfering RNAs (siRNAs), MicroRNAs and NPs in gynecological cancers

Chapter 06

Nanoparticle-based RNA (siRNA) combination therapy toward overcoming drug resistance in cancer

Chapter 07

Imaging modalities delivery of RNAi therapeutics in cancer therapy and clinical applications

Chapter 08

Recent development of Silica nanoparticles as delivery biomedical applications for cancer imaging and therapy

Chapter 09

Application of carbon nanotubes (CNTs) in cancer vaccines as drug delivery tools

Chapter 10

Development of oligonucleotides delivery, (siRNAs), and (miRNA) systems for anticancer therapeutic strategy immunotherapy

Chapter 11

Pharmacogenomics-synergistic strategies using a chimerical peptide for enhanced chemotherapy based on ROS and DNA nanosystem

Chapter 12

Pharmacokinetics, biodistribution and therapeutic applications of recently-developed siRNA and DNA repair genes recurrence

Chapter 13

Nanotechnologies assemblies of siRNA and chemotherapeutic drugs co-delivered for cancer therapeutic applications

Chapter 14

Targeted systemic combinatorial delivery of siRNA polyplexes-Functional quantum dot-siRNA nanoplexes

Chapter 15

Recent advances of nanotechnologies for cancer immunotherapy treatment

List of Abbreviations
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
siRNA Delivery;Nanoparticles;Delivery Systems;Drug targeted delivery;MCF-7 Cell;Nanocarrier;RNAi Therapeutics;AuNPs;siRNA Therapeutics;SiNPs;Mesoporous Silica Nanoparticles;Cancer treatment;Gene Silencing;Cationic Liposomes;EPR Effect;Codelivery System;HBV DNA;HBV Infection;Endosomal Escape;Cationic Lipid;Naked siRNA;DNA Nanostructures;Mitochondrial Delivery;Papillary Thyroid Cancer;P53 DNA;Combinatorial Nanoparticles;RNA NPs;Peptide Micelles;Free HA;DNA Complex;Intracellular ROS